Terkko Navigator / Hematology/ Feeds

How I assess and manage the risk of bleeding during treatment of patients with venous thromboembolism.

Bi-specific and Split CAR T Cells Targeting CD13 and TIM3 Eradicate Acute Myeloid Leukemia.

Targeting Myeloid-Cell Specific Integrinα9β1 Inhibits Arterial Thrombosis in Mice.

Acetylsalicylic acid (ASA) inhibits intravascular coagulation during S. aureus-induced sepsis in mice.

NADPH oxidase controls pulmonary neutrophil infiltration in the response to fungal cell walls by limiting LTB4.

Multiple BCL2 mutations co-occurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax.

The CNS can be a safe space for CARs.

Teamwork makes the dream work in thrombopoiesis.

SLAM dunk for myelofibrosis?

PMBL: flying under the immune radar.

POD24 in MZL: a means to an end or an end point in itself?

What's behind chronic graft versus host disease incidence curves?

Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-

Peripheral Neuropathy in Hematologic Malignancies – Past, Present and Future

Chronic thromboembolic pulmonary hypertension from synchronous idiopathic upper extremity deep vein thrombosis and pulmonary embolism

In the South African setting, HIV-associated Burkitt lymphoma is associated with frequent leukaemic presentation, complex cytogenetic karyotypes, and adverse clinical outcomes

Phenotypic characterization of macrophages in the BMB sample of human acute leukemia

Wdr26 regulates nuclear condensation in developing erythroblasts.

Bone marrow aspirate LE cells at acute lupus presentation.

Peripherally inserted catheters causing thrombosis.

MicroRNA immunomodulating therapeutics.

Diversifying study design in pediatrics.

Brentuximab vedotin with chemotherapy for Stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study.

A Research-Driven Approach to the Identification of Novel Natural Killer Cell Deficiencies Affecting Cytotoxic Function.

Rapid and Accurate Bayesian Diagnosis of Heparin-induced thrombocytopenia.

Increased activation of PI3 kinase-δ predisposes to B cell lymphoma.

Introduction to a Review Series on Understanding and Treating Primary Immunodeficiency.

Immune dysregulation in patients with RAG deficiency and other forms of combined immune deficiency.

Primary immunodeficiencies reveal the molecular requirements for effective host defense against EBV infection.

Virus specific T-cell Therapies for Patients with Primary Immune Deficiency.

Current Genetic Landscape in Common Variable Immune Deficiency.

The effect of serum pretreatment regimens for the detection of HLA class I antibodies in platelet‐refractory patients

Human B cells infected by Trypanosoma cruzi undergo F-actin disruption and cell death via caspase-7 activation and cleavage of phospholipase Cγ1

Effect of Hydroxyurea Treatment on the Inflammatory Markers Among Children With Sickle Cell Disease

Blood Group Types O and Non-O Are Associated With Coronary Collateral Circulation Development

First-in-human phase I study of BPI-9016M, a dual MET/Axl inhibitor, in patients with non-small cell lung cancer

Correction: BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications

Correction: The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML

A survey of transfusion practitioners in international society of blood transfusion member countries

After 95 years, it's time to eRASe JMML

Recognition of synthetic polyanionic ligands underlies“spontaneous” reactivity of Vγ1 γδTCRs

Alpha-Thalassemia Carrier due to -α3.7 Deletion: Not So Silent.

High-Parametric Evaluation of Human Invariant Natural Killer T Cells to Delineate Heterogeneity in Allo- and Autoimmunity.

Molecular dynamics during reduction of TKI dose reliably identify molecular recurrence after treatment cessation in CML.

External Validation of Models for KIR2DS1/KIR3DL1-informed Selection of Hematopoietic Cell Donors fails.

Improved transplant survival and long-term disease outcome in children with MHC class II deficiency.

Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML.

IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution.

Prevalence and disease predisposition of p.A91V perforin in an aged Caucasian population.

Dnmt3a loss and Idh2 neomorphic mutations mutually potentiate malignant hematopoiesis.